AWS to Infuse Another $20M Into Its Health Equity Program

Amazon Web Services (AWS) is adding $20 million to its health equity initiative, bringing its total investment to $60 million. The program aims to address health disparities highlighted by the pandemic. AWS has already distributed more than $30 million to 28 countries and partnered with 230 organizations. Their priorities include increasing access to quality health…

Read More

Treatment De-escalation Not Effective in Metastatic CRC

In the phase 3 ERMES study, treatment de-escalation was found to be ineffective in previously untreated, metastatic colorectal cancer (CRC) patients. The study compared the effectiveness of de-escalated treatment with FOLFIRI/cetuximab until progression. However, de-escalated treatment did not meet the noninferiority endpoint for progression-free survival, with a median PFS of 10.0 months compared to 12.2…

Read More

FDA Warning: Prolia | Medical News Bulletin

Patients with chronic kidney disease who use Prolia are at higher risk of developing dangerously low calcium levels, known as hypocalcemia. This can be particularly dangerous for patients undergoing dialysis or with mineral and bone density disorder. The FDA advises patients to contact their doctor to discuss the best medication regimen and be aware of…

Read More

Contributed: ​​AI integration in patient diagnostics: revolutionizing healthcare in 2024

In 2023, the healthcare sector experienced a transformation due to the integration of artificial intelligence (AI) in patient diagnostics, leading to increased efficiency, accuracy, and personalization. AI-driven diagnostics revolutionizes how medical professionals approach diagnosis by analyzing patient data swiftly and aiding in identifying diseases at early stages. AI-driven diagnostic tools are being used in interpreting…

Read More

The FTC Escalates Biden’s Fight Against Drug Prices

The Federal Trade Commission is taking aggressive action against anticompetitive practices in the healthcare industry. It has issued stricter guidelines to prevent hospital mergers and investigated practices in the drug supply chain. The FTC challenged the validity of over 100 drug patents listed in the FDA’s “Orange Book,” which can delay approval for generic competitors….

Read More

Familial SCAD linked to aggregation of common genetic variants

Research has shown that high concentrations of common genetic variants within families are associated with an increased inherited risk for spontaneous coronary artery dissection (SCAD). Rarer genes associated with inherited connective tissue disorders were not found to be associated with SCAD risk. The study was based on a cohort of 1,352 genotyped individuals, including healthy…

Read More

Parkinson’s study, Gilead, CG Oncology

The article discusses various developments in the biotech industry, including the challenges faced by venture capitalists, Gilead Sciences’ investment in oncology, an upcoming IPO for an obesity-related company, and new research in Parkinson’s disease treatments. It also mentions other relevant news and offers readers the option to sign up for a biotech newsletter. The industry…

Read More
error: Content is protected !!